YouTube

Pediatime Logo

YouTube: Subscribe to Pediatime!

Stay updated with the latest pediatric education videos.

Subscribe Now

Castleman Disease in Children

Definition & Epidemiology

  • Rare lymphoproliferative disorder characterized by abnormal lymph node enlargement
  • Peak incidence: Adolescence and early adulthood
  • No gender predilection
  • Incidence: approximately 21-25 cases per million person-years

Pathophysiology

  • Key pathogenic mechanisms:
    • Dysregulated production of IL-6
    • HHV-8 infection (in some cases)
    • VEGF overexpression
    • Immune system dysregulation
  • Associated conditions:
    • HIV infection
    • Autoimmune disorders
    • POEMS syndrome

Disease Classification

Histopathological Variants

  • Hyaline Vascular Type (HVV)
    • Most common in children (90%)
    • Characterized by:
      • Hyalinized follicles
      • "Lollipop" formations
      • Increased vascularity
  • Plasma Cell Type (PCV)
    • Less common in children
    • Features:
      • Sheets of mature plasma cells
      • Preserved lymph node architecture
  • Mixed Type
    • Shows features of both HVV and PCV
    • Intermediate prognosis

Clinical Subtypes

  • Unicentric Castleman Disease (UCD)
    • Single lymph node station
    • Usually HVV type
    • Better prognosis
  • Multicentric Castleman Disease (MCD)
    • Multiple lymph node regions
    • Usually plasma cell or mixed type
    • Subtypes:
      • HHV-8 positive
      • HHV-8 negative/idiopathic (iMCD)

Clinical Manifestations

Unicentric Disease

  • Local symptoms:
    • Single enlarged lymph node/mass
    • Compression symptoms
    • Usually asymptomatic
  • Common locations:
    • Thorax (70%)
    • Neck (14%)
    • Abdomen (12%)
    • Axilla (4%)

Multicentric Disease

  • Systemic symptoms:
    • Fever
    • Night sweats
    • Weight loss
    • Fatigue
    • Growth failure
  • Laboratory abnormalities:
    • Anemia
    • Thrombocytopenia
    • Elevated inflammatory markers
    • Hypergammaglobulinemia
  • Organ involvement:
    • Hepatosplenomegaly
    • Fluid retention
    • Skin manifestations
    • Renal dysfunction

Diagnostic Approach

Initial Evaluation

  • Laboratory studies:
    • Complete blood count
    • Comprehensive metabolic panel
    • LDH, CRP, ESR
    • IL-6 levels
    • HIV testing
    • HHV-8 testing
  • Imaging:
    • CT with contrast
    • PET-CT for staging
    • MRI for specific locations

Definitive Diagnosis

  • Excisional lymph node biopsy
    • Essential for histological classification
    • Immunohistochemistry
    • Flow cytometry
  • Diagnostic criteria for iMCD:
    • Major criteria (2 required):
      • Characteristic histopathology
      • Multicentric lymphadenopathy
    • Minor criteria (2-3 required):
      • Elevated CRP/ESR
      • Anemia
      • Thrombocytopenia/thrombocytosis
      • Constitutional symptoms
      • Organomegaly


Case-1

A male child, at the age of 13 years presented with a mass in the anterior part of the neck

CT scan showed that the neck mass, a multiple lymph node enlargement, with an high contrast-enhancement, originated in the anterior-superior mediastinum and cause a serious right dislocation of the trachea (A-D). (source)

Histology showed small germinal center depleted of follicular center B cells, and penetration by hyalinized venules (A); follicular dendritic cell were evidenced by their strong immunoreactivity for CD 35 (B); immunoreactivity for CD20 (C) and CD3 (D) was strongly positive. (source)

Treatment Approach

Unicentric Disease

  • Primary treatment:
    • Complete surgical excision (curative)
    • Radiation therapy if unresectable
  • Follow-up:
    • Regular monitoring
    • Imaging surveillance

Multicentric Disease

  • First-line therapy:
    • Anti-IL-6 therapy:
      • Siltuximab
      • Tocilizumab
    • HHV-8 positive MCD:
      • Rituximab
      • Antiviral therapy
  • Second-line options:
    • Chemotherapy:
      • CHOP protocol
      • CVP regimen
    • Immunomodulators:
      • Thalidomide
      • Sirolimus
    • Corticosteroids

Supportive Care

  • Management of complications
  • Growth monitoring
  • Psychosocial support
  • Regular assessment of disease activity
  • Prevention of infections


Castleman Disease in Children
  1. What is another name for Castleman Disease?
    Answer: Giant lymph node hyperplasia or angiofollicular lymph node hyperplasia
  2. Who first described Castleman Disease?
    Answer: Dr. Benjamin Castleman
  3. What are the two main clinical types of Castleman Disease?
    Answer: Unicentric (localized) and Multicentric
  4. Which type of Castleman Disease is more common in children?
    Answer: Unicentric (localized) Castleman Disease
  5. What are the three main histological variants of Castleman Disease?
    Answer: Hyaline vascular, plasma cell, and mixed type
  6. Which histological variant is most common in pediatric Castleman Disease?
    Answer: Hyaline vascular type
  7. What is the most common site of involvement in unicentric Castleman Disease in children?
    Answer: Mediastinum
  8. Is Castleman Disease considered a neoplastic or reactive condition?
    Answer: Generally considered a lymphoproliferative disorder, with some debate about its nature
  9. What virus is associated with some cases of multicentric Castleman Disease?
    Answer: Human Herpesvirus 8 (HHV-8)
  10. Is HHV-8 commonly associated with unicentric Castleman Disease in children?
    Answer: No, it's rarely associated with unicentric disease
  11. What cytokine plays a key role in the pathogenesis of Castleman Disease?
    Answer: Interleukin-6 (IL-6)
  12. What are the typical symptoms of unicentric Castleman Disease in children?
    Answer: Often asymptomatic, may present with a painless mass
  13. What are common systemic symptoms in multicentric Castleman Disease?
    Answer: Fever, night sweats, weight loss, fatigue
  14. What is the first-line treatment for unicentric Castleman Disease in children?
    Answer: Surgical excision
  15. Is chemotherapy typically used for unicentric Castleman Disease in children?
    Answer: No, it's rarely needed for unicentric disease
  16. What is the role of rituximab in treating Castleman Disease?
    Answer: It's used in some cases of multicentric Castleman Disease, especially HHV-8 associated cases
  17. Can Castleman Disease transform into lymphoma?
    Answer: Yes, particularly in multicentric cases
  18. What is the prognosis for children with unicentric Castleman Disease after complete surgical excision?
    Answer: Excellent, with very low recurrence rates
  19. Is anemia a common finding in Castleman Disease?
    Answer: Yes, particularly in multicentric disease
  20. What imaging modality is typically used for initial evaluation of suspected Castleman Disease?
    Answer: CT scan or MRI
  21. Can PET-CT be useful in evaluating Castleman Disease?
    Answer: Yes, particularly for assessing disease extent in multicentric cases
  22. What is POEMS syndrome and how is it related to Castleman Disease?
    Answer: POEMS is a rare paraneoplastic syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, Skin changes) that can be associated with Castleman Disease
  23. Is thrombocytosis or thrombocytopenia more common in Castleman Disease?
    Answer: Thrombocytosis is more common
  24. What is the typical age of onset for unicentric Castleman Disease in children?
    Answer: It can occur at any age, but often presents in adolescence
  25. Can Castleman Disease affect the spleen?
    Answer: Yes, particularly in multicentric disease
  26. What is the role of anti-IL-6 therapy in Castleman Disease?
    Answer: It's used in some cases of multicentric Castleman Disease, particularly those refractory to other treatments
  27. Is multicentric Castleman Disease associated with HIV infection?
    Answer: Yes, HIV-positive individuals are at higher risk for multicentric Castleman Disease
  28. What is the typical serum IL-6 level in active Castleman Disease?
    Answer: Elevated
  29. Can Castleman Disease present with nephrotic syndrome?
    Answer: Yes, it's a rare presentation but has been reported
  30. What is the role of corticosteroids in treating Castleman Disease?
    Answer: They can be used for symptomatic relief, particularly in multicentric disease


Disclaimer

The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.





Powered by Blogger.